Literature DB >> 33754950

Per- and polyfluoroalkyl mixtures toxicity assessment "Proof-of-Concept" illustration for the hazard index approach.

M M Mumtaz1, M C Buser1, H R Pohl1.   

Abstract

The 2018 ATSDR mixture framework recommends three approaches including the hazard index (HI) for environmental mixture toxicity assessment. Per- and polyfluoroalkyls (PFAS) are found in our environment and general populations. Recent experimental mixture toxicity studies of perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) and an assessment of 17 PFAS indicate the use of additivity for their joint toxicity assessment. The aim of this investigation was to detail the stepwise procedures and examine the extent and use of the HI approach for PFAS mixture assessment. Using estimated general public lifetime exposures (high, medium, and low), binary mixtures of PFOS and PFOA yielded, respectively, hazard indices (HIs) of 30.67, 8.33, and 3.63 for developmental toxicity; 10.67, 5.04, and 2.34 for immunological toxicity; 3.57, 1.68, and 0.78 for endocrine toxicity; 4.51, 1.73, and 0.79 for hepatic toxicity; and 15.08, 2.29, and 0.88 for reproductive toxicity. A heterogeneous mixture of PFOA, PFAS, dioxin (CDD), and polybrominated compounds (PBDE) for high exposure scenario yielded HIs of 30.99 for developmental, 10.77 for immunological, 3.64 for endocrine, 4.61 for hepatic, and 17.36 for reproductive effects. The HI values are used as a screening tool; the potential concern for exposures rises as HI values increase. For HI values >1, a follow-up including further analysis of specific exposures, use of internal dosimetry, and uncertainty factors is conducted before recommending appropriate actions. The HI approach appears suitable to address present-day PFAS public health concerns for initial assessment of multiple health effects, until further insights are gained into their mechanistic toxicology.The findings and conclusions in this article are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/the Agency for Toxic Substances and Disease Registry.

Entities:  

Keywords:  PFAS; hazard index; mixtures

Mesh:

Substances:

Year:  2021        PMID: 33754950      PMCID: PMC9069224          DOI: 10.1080/15287394.2021.1901251

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  47 in total

1.  Serum levels of per- and polyfluoroalkyl substances alternatives and blood pressure by sex status: Isomers of C8 health project in China.

Authors:  Xin Mi; Yun-Qing Yang; Mohammed Zeeshan; Zhi-Bin Wang; Xiao-Yun Zeng; Yang Zhou; Bo-Yi Yang; Li-Wen Hu; Hong-Yao Yu; Xiao-Wen Zeng; Ru-Qing Liu; Guang-Hui Dong
Journal:  Chemosphere       Date:  2020-07-19       Impact factor: 7.086

2.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Authors:  Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar
Journal:  Toxicol Sci       Date:  2006-01-16       Impact factor: 4.849

Review 3.  A weight-of-evidence approach for assessing interactions in chemical mixtures.

Authors:  M M Mumtaz; P R Durkin
Journal:  Toxicol Ind Health       Date:  1992 Nov-Dec       Impact factor: 2.273

4.  Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.

Authors:  Jamie C DeWitt; Wanda C Williams; N Jonathan Creech; Robert W Luebke
Journal:  J Immunotoxicol       Date:  2015-01-16       Impact factor: 3.000

5.  Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Authors:  Rachel Rogers Worley; Susan McAfee Moore; Bruce C Tierney; Xiaoyun Ye; Antonia M Calafat; Sean Campbell; Million B Woudneh; Jeffrey Fisher
Journal:  Environ Int       Date:  2017-06-20       Impact factor: 9.621

6.  Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.

Authors:  Rachel Rogers Worley; Jeffrey Fisher
Journal:  Toxicol Appl Pharmacol       Date:  2015-11-06       Impact factor: 4.219

7.  Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.

Authors:  Joseph J Shearer; Catherine L Callahan; Antonia M Calafat; Wen-Yi Huang; Rena R Jones; Venkata S Sabbisetti; Neal D Freedman; Joshua N Sampson; Debra T Silverman; Mark P Purdue; Jonathan N Hofmann
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

8.  Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.

Authors:  Vaughn Barry; Andrea Winquist; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2013-09-05       Impact factor: 9.031

9.  Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Esben Budtz-Jørgensen
Journal:  Environ Health Perspect       Date:  2017-07-26       Impact factor: 9.031

10.  Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study.

Authors:  Joseph M Braun; Aimin Chen; Megan E Romano; Antonia M Calafat; Glenys M Webster; Kimberly Yolton; Bruce P Lanphear
Journal:  Obesity (Silver Spring)       Date:  2015-11-11       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.